Back
Alnylam Pharmaceuticals Stock Price Chart
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.
Buy
56
ALNY
Alnylam Pharmaceuticals
Last Price:
$308.05
Seasonality Move:
20.84%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 297.28 | Buy |
| 20-day SMA: | 285.14 | Buy |
| 50-day SMA: | 264.45 | Buy |
| 200-day SMA: | 262.36 | Buy |
| 8-day EMA: | 298.64 | Buy |
| 20-day EMA: | 286.99 | Buy |
| 50-day EMA: | 271.98 | Buy |
| 200-day EMA: | 252.64 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.93 | Buy |
| Relative Strength Index (14 RSI): | 67.42 | Buy |
| Chaikin Money Flow: | -55071 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (264.67 - 297.23) | Buy |
| Bollinger Bands (100): | (241.18 - 280.8) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 305.31 while ALNY 8-day simple moving average is 297.28, which is a Buy signal.
-
The stock price of ALNY is 305.31 while Alnylam Pharmaceuticals 20-day SMA is 285.14, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day simple moving average is 264.45 while ALNY share price is 305.31, making it a Buy technically.
-
ALNY stock price is 305.31 and Alnylam Pharmaceuticals 200-day simple moving average is 262.36, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Buy
56
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a BuyThe current Alnylam Pharmaceuticals [ALNY] share price is $305.31. The Score for ALNY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
39.8B
Price in USD:
305.31
Share Volume:
563.1K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
308.93
52-Week Low:
147.25
Buy
56
Alnylam Pharmaceuticals (ALNY)
is a Buy
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 305.31 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is not overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 305.31 while ALNY 8-day exponential moving average is 298.64, which is a Buy signal.
-
The stock price of ALNY is 305.31 while Alnylam Pharmaceuticals 20-day EMA is 286.99, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 271.98 while ALNY share price is 305.31, making it a Buy technically.
-
ALNY stock price is 305.31 and Alnylam Pharmaceuticals 200-day simple moving average is 252.64, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $1.03 per share, an increase next quarter of $1.64 per share, an increase this year of $1.17 per share, and an increase next year of $3.11 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is 11.93, suggesting Alnylam Pharmaceuticals is a Buy
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 67.42, which suggest Alnylam Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (264.67 - 297.23), which suggest Alnylam Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (241.18 - 280.8), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.